Scopus BioPharma Inc (OTCPK:SCPS)
$ 0.0001 0 (0%) Market Cap: 4,000.00 Enterprise Value: -358,000.00 PE Ratio: 0 PB Ratio: 0 GF Score: 0/100

Scopus Biopharma Inc at Benzinga Healthcare Small Cap Conference (Virtual) Transcript

Sep 29, 2021 / 08:20PM GMT
Release Date Price: $4.01 (+0.25%)
Spencer Israel
Benzinga - Media

For the final presentation on track relative to the green track rate, I can remember, and this is the green one versus the green one Brent was on the blue one on the green one, whatever final presentation is here. Let's bring on Allen Horsager. I hope I got your last name history,

Alan Horsager
Scopus BioPharma Inc. - President, Immuno-Oncology

[Of course, Horsager but I get Horsager] or I get many permutations of that name, sounds pretty good.

Spencer Israel
Benzinga - Media

You are the CEO of a couple of companies actually, and you're here to speak to the launch of all of one of them, right, Duet Therapeutics. And so if we can, Alan, let's get your slides. I'll just go ahead and mentioned earlier, you can click share screen on the bottom, but you bring up your slides, put them in slideshow mode.

Alan Horsager;Spencer Israel
Scopus BioPharma Inc. - President, Immuno-Oncology;

[And you seem Spencer?]

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot